Percheron Therapeutics, previously known as Antisense, has appointed biotech executive Dr Michael Baker as its new chief executive officer and managing director, as current CEO Dr James Garner prepares to leave the role for an overseas opportunity. …
Percheron turns to former Arovella chief Michael Baker for next phase of HMBD 002 development
August 10, 2026 Latest NewsAustralian BiotechBioPharmaDispatch Executive
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 11 September
September 11, 2026 - - Podcast -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
AI Health Summit 2026
September 10, 2026 - - Summit -
Taking a stake is not the same as spectating investor risk and expecting a benefit
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News